在口服双胞胎菌补充剂ICC患者免疫治疗后预测益处的诺莫图:一项回顾性研究

Sihui Zhu1,2, Yuncheng Jin1, Juan Zhang1

  • 1Department of Oncology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University & Clinical Cancer Institute of Nanjing University, Nanjing, 210008, Jiangsu Province, China.

BMC cancer
|October 14, 2024
PubMed
概括

这项研究开发了名图来预测接受免疫治疗的肝脏内胆管癌 (ICC) 患者的结果. 益生菌作为一种新的预后标志物出现,有助于治疗选择和决策.